Orelox

Country: New Zealand

Language: English

Source: Medsafe (Medicines Safety Authority)

Active ingredient:

Cefpodoxime proxetil 10.4 mg/mL equivalent to 8 mg/ml cefpodoxime

Available from:

sanofi-aventis new zealand limited

INN (International Name):

Cefpodoxime proxetil 10.4 mg/mL (= 8 mg/ml cefpodoxime)

Dosage:

40 mg/5mL

Pharmaceutical form:

Granules for oral suspension

Composition:

Active: Cefpodoxime proxetil 10.4 mg/mL equivalent to 8 mg/ml cefpodoxime Excipient: Aspartame Banana oil Carmellose calcium Carmellose sodium Citric acid monohydrate Colloidal silicon dioxide Hyprolose Iron oxide yellow Lactose monohydrate Monosodium glutamate Potassium sorbate Purified talc Sodium chloride Sorbitan trioleate Sucrose

Units in package:

Bottle, glass, 100 mL

Class:

Prescription

Prescription type:

Prescription

Manufactured by:

Daiichi Sankyo Propharma Co. Limited

Product summary:

Package - Contents - Shelf Life: Bottle, glass, - 100 mL - 24 months from date of manufacture stored at 15°C to 25°C (Controlled room temp) 10 days reconstituted stored at 2° to 8°C (Refrigerate, do not freeze)

Authorization date:

1993-06-14